GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
In clinical studies, patients with osteoarthritis of the knee demonstrated a significant improvement in pain (vs. a placebo) starting at 1 week that was sustained through 12 weeks of treatment.
Moreover, Gardner said, “One of my concerns about treating osteoarthritis is I don ... toward greater procedural/injection site pain in the RTX treatment groups, compared with placebo, most ...
and treatment options. However, there are some similarities in symptoms, as they both involve joint pain. Although RA and OA both affect your joints, they’re very different forms of arthritis.